Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dendritic cell vaccination for Lynch syndrome or MSI-positive colorectal cancer
NL-OMON39056Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2010
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of CEA/frameshift neoantigen-loaded dendritic cell vaccine in colorectal cancer (CRC) and hereditary nonpolyposis colorectal cancer (HNPCC), sponsored by Radboud University Medical Center. Started Dec 2010; status: active, not recruiting.
02
Drugs
CEA/frameshift neoantigen-loaded dendritic cell vaccine
03
Conditions
colorectal cancer (CRC)hereditary nonpolyposis colorectal cancer (HNPCC)
Beyond the preview
Go deeper on NL-OMON39056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39056.